Plunkett Research Online: Lineage Cell Therapeutics Inc

LINEAGE CELL THERAPEUTICS INC (LCTX:ASE) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. The firm’s focus is to develop therapies for degenerative retinal diseases, neurological conditions associated with demyelination and aiding the body in detecting and c.....



Lineage Cell Therapeutics Inc
Ticker: LCTX
Exchange: ASE
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 442-287-8990
Fax:
Address: 2173 Salk Avenue
Suite 200
Carlsbad, CA 92008 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Drugs-Surgical
Biotechnology
Cell Therapy Development
Clinical Tetsting
Cell Replacement
Contacts Description

Brian Culley CEO
Kevin L. Cook CFO
See More
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. The firm’s focus is to develop therapies for degenerative retinal diseases, neurological conditions associated with demyelination and aiding the body in detecting and c.....See More See More

Auditor: OUM & Co. LLP
Legal Advisor: Thompson, Welch, Soroko & Gilbert LLP
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017 2016 2015
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
OpRegen
OPC1
VAC2
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: